Navigation Links
Nucletron Increases Full Year Outlook After Strong First Half 2009

VEENENDAAL, the Netherlands, September 3 /PRNewswire/ --

- Despite Challenging Global Economic Conditions, Nucletron Surpassed Projections for the First Half Year

Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009. Despite challenging global economic conditions, Nucletron surpassed projections for the first half year.

Net sales amounted to EUR 51.2 million, a 3% growth on like-for-like basis compared to the first half of 2008. EBITDA in the first half of 2009 amounted to EUR 6.3 million, a 53% increase compared to EUR 4.1 million over the same period last year. As a result of the positive developments Nucletron expects full year EBITDA to increase to EUR 19.0 million.

Jos Lamers, chief executive officer of Nucletron, comments: "Over the first six months of 2009, we have seen the results of our improved focus on innovation and our increased marketing efforts. Our senior management team is at full strength after the appointment of three new team members with a blue chip background. Combining our strength in marketing and sales with the research & development capabilities of Isodose Control will make Nucletron one of the global leaders in brachytherapy. Given our many upcoming product releases in the months ahead, we are on track to outperform our 2009 goals."

Among the several advancements made in the first half of 2009, Nucletron partnered with Advanced Radiation Therapy (ART) to offer a revolutionary solution for treating breast cancer. AccuBoost allows clinicians to use image-guidance, as used in a standard mammography, to pinpoint radiation directly to the tumour site. This allows for much better accuracy in targeting the radiation to the cancerous area, while protecting the patients' healthy organs during treatment.

The business collaboration with Isodose Control is now in place. The partnership allows clinicians to benefit from Nucletron's leadership and strength in brachytherapy with Isodose Control's track record of innovation.

Additionally, Nucletron launched its latest evolution in treatment planning for radiotherapy. Model-based segmentation in Oncentra MBS and volumetric modulated arc therapy with Oncentra VMAT ensure quality, while dramatically reducing the time needed to create treatment plans.

Visit our website

About Nucletron

Nucletron is a global leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians.

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
2. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
3. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
4. Fat on chest and upper back increases risk of insulin resistance
5. Handling Stress Properly Increases Good Cholesterol
6. High alcohol consumption increases stroke risk among Chinese men
7. High alcohol consumption increases stroke risk, Tulane study says
8. Genetic predisposition increases childhood asthma risk
9. Smoking increases risks for head and neck cancers for men and women
10. Passive smoking increases sleep disturbance among pregnant women
11. Frequent alcohol consumption increases cancer risk in older women
Post Your Comments:
(Date:11/25/2015)... Canadian, OK (PRWEB) , ... November 25, 2015 , ... ... and International training center for the Narconon network, announced the release of a new ... Since 1966 the Narconon organization has been working with drug- and alcohol-addicted individuals with ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 ... Tri Lite’s personal heating products business. Cozy Products explains what this means for ... fit in well with the Cozy Products business model: to sell personal heaters that ...
(Date:11/25/2015)... Calif. (PRWEB) , ... November 25, 2015 , ... Beddit® ... and Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ ... and understand how well you slept. The SleepScore is created by a proprietary algorithm. ...
(Date:11/25/2015)... , ... November 25, 2015 , ... “While riding the ... inventor, from Bronx, N.Y. “I thought there had to be a convenient and comfortable ... PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or inclement ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for ... The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Japanese therapeutic drug monitoring market, including ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
Breaking Medicine Technology: